TOLL vs. HRTS

Last updated Jun 4, 2026

TOLL (Tema Monopolies and Oligopolies ETF) and HRTS (Tema Obesity & Cardiometabolic ETF) are both exchange-traded funds - TOLL is a Large Cap Growth Equities fund actively managed by Tema, while HRTS is a Health & Biotech Equities fund actively managed by Tema. Both are actively managed. Over the past year, TOLL returned 19.11% vs 20.97% for HRTS. A 0.58 correlation means they provide meaningful diversification when combined. TOLL charges 0.55%/yr vs 0.75%/yr for HRTS.

Performance

TOLL vs. HRTS - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Tema Monopolies and Oligopolies ETF (TOLL) and Tema Obesity & Cardiometabolic ETF (HRTS). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, TOLL achieves a 13.26% return, which is significantly higher than HRTS's -5.70% return.

TOLL

• 1D: 0.58%
• 1M: 7.88%
• YTD: 13.26%
• 6M: 14.02%
• 1Y: 19.11%
• 3Y*: 17.47%
• 5Y*: —
• 10Y*: —

HRTS

• 1D: 0.51%
• 1M: -0.90%
• YTD: -5.70%
• 6M: -5.48%
• 1Y: 20.97%
• 3Y*: —
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

TOLL vs. HRTS - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023
TOLL Tema Monopolies and Oligopolies ETF	13.26%	11.36%	12.79%	7.45%
HRTS Tema Obesity & Cardiometabolic ETF	-5.70%	23.93%	-4.30%	14.97%

Correlation

The correlation between TOLL and HRTS is 0.52, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.52
Correlation (All Time) Calculated using the full available price history since Nov 22, 2023	0.59

The correlation between TOLL and HRTS has been stable across timeframes, ranging from 0.52 to 0.58 - a consistent structural relationship.

TOLL vs. HRTS - Sectors Allocation Comparison

Sectors	TOLL	HRTS
Technology	32.0%	-
Financial Services	26.5%	-
Industrials	16.9%	-
Healthcare	12.7%	100.0%
Consumer Defensive	7.0%	-
Basic Materials	3.4%	-
Utilities	1.6%	-
Communication Services	-	-
Consumer Cyclical	-	-
Energy	-	-
Real Estate	-	-

Return for Risk

TOLL vs. HRTS — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

TOLL

TOLL Risk / Return Rank: 38
TOLL Sharpe Ratio Rank: 38
TOLL Sortino Ratio Rank: 38
TOLL Omega Ratio Rank: 36
TOLL Calmar Ratio Rank: 35
TOLL Martin Ratio Rank: 41

HRTS

HRTS Risk / Return Rank: 36
HRTS Sharpe Ratio Rank: 37
HRTS Sortino Ratio Rank: 38
HRTS Omega Ratio Rank: 33
HRTS Calmar Ratio Rank: 39
HRTS Martin Ratio Rank: 32

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

TOLL vs. HRTS - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Tema Monopolies and Oligopolies ETF (TOLL) and Tema Obesity & Cardiometabolic ETF (HRTS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	TOLL	HRTS	Difference
Sharpe ratio: Return per unit of total volatility	1.35	1.31	+0.03
Sortino ratio: Return per unit of downside risk	1.96	1.99	-0.03
Omega ratio: Gain probability vs. loss probability	1.24	1.23	+0.01
Calmar ratio: Return relative to maximum drawdown	1.70	1.91	-0.21
Martin ratio: Return relative to average drawdown	6.49	4.83	+1.67
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

TOLL vs. HRTS - Sharpe Ratio Comparison

The current TOLL Sharpe Ratio is 1.35, which is comparable to the HRTS Sharpe Ratio of 1.31. The chart below compares the historical Sharpe Ratios of TOLL and HRTS, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	TOLL	HRTS	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	1.35	1.31	+0.03
Sharpe Ratio (All Time) Calculated using the full available price history	1.12	0.55	+0.57

Drawdowns

TOLL vs. HRTS - Drawdown Comparison

The maximum TOLL drawdown since its inception was -15.54%, smaller than the maximum HRTS drawdown of -25.81%. Use the drawdown chart below to compare losses from any high point for TOLL and HRTS.

Drawdown Indicators

	TOLL	HRTS	Difference
Max Drawdown Largest peak-to-trough decline	-15.54%	-25.81%	+10.27%
Max Drawdown (1Y) Largest decline over 1 year	-11.26%	-11.01%	-0.25%
Max Drawdown (3Y) Largest decline over 3 years	-15.54%	—	—
Current Drawdown Current decline from peak	0.00%	-9.14%	+9.14%
Average Drawdown Average peak-to-trough decline	-2.39%	-9.02%	+6.63%
Ulcer Index Depth and duration of drawdowns from previous peaks	2.95%	4.36%	-1.41%

Volatility

TOLL vs. HRTS - Volatility Comparison

Tema Monopolies and Oligopolies ETF (TOLL) and Tema Obesity & Cardiometabolic ETF (HRTS) have volatilities of 4.64% and 4.44%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	TOLL	HRTS	Difference
Volatility (1M) Calculated over the trailing 1-month period	4.64%	4.44%	+0.20%
Volatility (6M) Calculated over the trailing 6-month period	11.68%	11.26%	+0.42%
Volatility (1Y) Calculated over the trailing 1-year period	14.25%	16.03%	-1.78%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	15.82%	19.07%	-3.25%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	15.82%	19.07%	-3.25%

TOLL vs. HRTS - Expense Ratio Comparison

TOLL has a 0.55% expense ratio, which is lower than HRTS's 0.75% expense ratio.

Dividends

TOLL vs. HRTS - Dividend Comparison

TOLL's dividend yield for the trailing twelve months is around 0.28%, less than HRTS's 1.42% yield.

Position	TTM	2025	2024	2023
HRTS Tema Obesity & Cardiometabolic ETF	1.42%	1.34%	1.63%	0.00%
TOLL Tema Monopolies and Oligopolies ETF	0.28%	0.32%	1.99%	0.36%

Frequently Asked Questions

Can I hold both TOLL and HRTS in my portfolio?

TOLL and HRTS have a correlation of 0.52, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, TOLL or HRTS?

TOLL has higher volatility (4.64%) compared to HRTS (4.44%). In terms of maximum drawdown, TOLL dropped -15.54% vs HRTS's -25.81%.

Which ETF is better, TOLL or HRTS?

On 1-year performance, HRTS leads with 20.97% vs 19.11% for TOLL. On fees, TOLL is cheaper at 0.55% per year. On volatility, HRTS has been the lower-risk option at 4.44%. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF has performed better, TOLL or HRTS?

Over the 1-year period, HRTS has performed better with a 20.97% return vs 19.11%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

Which ETF is cheaper, TOLL or HRTS?

TOLL is cheaper with a 0.55% expense ratio, compared with 0.75% for HRTS.

Which ETF pays a higher dividend yield, TOLL or HRTS?

HRTS has the higher dividend yield at 1.42%, compared with 0.28% for TOLL.

What is the main difference between TOLL and HRTS?

TOLL is categorized as Large Cap Growth Equities, while HRTS is Health & Biotech Equities. Their fees differ too: 0.55% for TOLL and 0.75% for HRTS.

Which has better risk-adjusted returns?

TOLL currently has the higher Sharpe Ratio (1.35 vs 1.31), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.